BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Zinc(II) ion promotes anti-inflammatory effects of rhSOD3 by increasing cellular association

  • Kim, Younghwa (Department of Emergency Medical Technology, Kyungil University) ;
  • Jeon, Yoon-Jae (Laboratory of Dermato-Immunology, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea) ;
  • Ryu, Kang (RNS BIO) ;
  • Kim, Tae-Yoon (Laboratory of Dermato-Immunology, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea)
  • Received : 2016.08.25
  • Accepted : 2016.11.18
  • Published : 2017.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, we demonstrated that superoxide dismutase 3 (SOD3) is a strong candidate for biomedicine. Anti-oxidant function of SOD3 was accomplished without cell penetration, and it inhibited the inflammatory responses via non-enzymatic functions. SOD3 has the heparin binding domain associating cell surface. Interestingly, we found that $Zn^{2+}$ promotes transduction effects of recombinant human SOD3 (rhSOD3) by increasing uptake via the heparin binding domain (HBD). We demonstrated an uptake of rhSOD3 from media to cell lysate via HBD, resulting in an accumulation of rhSOD3 in the nucleus, which was promoted by the presence of $Zn^{2+}$. This resulted in increased inhibitory effects of rhSOD3 on NF-{\kappa}B and STAT3 signals in the presence of $Zn^{2+}$, which shows elevated association of rhSOD3 into the cells. These results suggest that an optimized procedure can help to enhance the inflammatory efficacy of rhSOD3, as a novel biomedicine.

Keywords

References

  1. Serra V, von Zglinicki T, Lorenz M and Saretzki G (2003) Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem 278, 6824-6830 https://doi.org/10.1074/jbc.M207939200
  2. Teoh ML, Fitzgerald MP, Oberley LW and Domann FE (2009) Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion. Cancer Res 69, 6355-6363 https://doi.org/10.1158/0008-5472.CAN-09-1195
  3. Wheeler MD, Smutney OM and Samulski RJ (2003) Secretion of extracellular superoxide dismutase from muscle transduced with recombinant adenovirus inhibits the growth of B16 melanomas in mice. Mol Cancer Res 1, 871-881
  4. Laukkanen MO, Kivela A, Rissanen T et al (2002) Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloondenuded rabbit aorta. Circulation 106, 1999-2003 https://doi.org/10.1161/01.CIR.0000031331.05368.9D
  5. Marklund SL (1990) Expression of extracellular superoxide dismutase by human cell lines. Biochem J 266, 213-219 https://doi.org/10.1042/bj2660213
  6. Marklund SL (1992) Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 267, 6696-6701
  7. Stralin P and Marklund SL (2000) Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis 151, 433-441 https://doi.org/10.1016/S0021-9150(99)00427-X
  8. Ookawara T, Kizaki T, Takayama E et al (2002) Nuclear translocation of extracellular superoxide dismutase. Biochem Biophys Res Commun 296, 54-61 https://doi.org/10.1016/S0006-291X(02)00804-5
  9. Green M and Loewenstein PM (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-1188 https://doi.org/10.1016/0092-8674(88)90262-0
  10. Frankel AD and Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193 https://doi.org/10.1016/0092-8674(88)90263-2
  11. Dixon JE, Osman G, Morris GE et al (2016) Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides. Proc Natl Acad Sci U S A 113, E291-299 https://doi.org/10.1073/pnas.1518634113
  12. Shrestha P, Yun JH, Kim WT, Kim TY and Lee W (2016) Cloning, purification, and characterization of recombinant human extracellular superoxide dismutase in SF9 insect cells. Mol Cells 39, 242-249 https://doi.org/10.14348/molcells.2016.2271
  13. Park KY, Kim EY, Lee W, Kim TY and Kim WT (2016) Expression, subcellular localization, and enzyme activity of a recombinant human extra-cellular superoxide dismutase in tobacco (Nicotiana benthamiana L.). Protein Expr Purif 119, 69-74 https://doi.org/10.1016/j.pep.2015.11.014
  14. Ryu K, Kim YH, Kim Y, Lee JS, Jeon B and Kim TY (2008) Increased yield of high-purity and active tetrameric recombinant human EC-SOD by solid phase refolding. J Microbiol Biotechnol 18, 1648-1654
  15. Auten RL, O'Reilly MA, Oury TD, Nozik-Grayck E and Whorton MH (2006) Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia. Am J Physiol Lung Cell Mol Physiol 290, L32-40 https://doi.org/10.1152/ajplung.00133.2005
  16. Gongora MC, Lob HE, Landmesser U et al (2008) Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. Am J Pathol 173, 915-926 https://doi.org/10.2353/ajpath.2008.080119
  17. Juul K, Tybjaerg-Hansen A, Marklund S, Lange P and Nordestgaard BG (2006) Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173, 858-864 https://doi.org/10.1164/rccm.200509-1387OC
  18. Oury TD, Day BJ and Crapo JD (1996) Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med 20, 957-965 https://doi.org/10.1016/0891-5849(95)02222-8
  19. Kwon MJ, Jeon YJ, Lee KY and Kim TY (2012) Superoxide dismutase 3 controls adaptive immune responses and contributes to the inhibition of ovalbumin-induced allergic airway inflammation in mice. Antioxid Redox Signal 17, 1376-1392 https://doi.org/10.1089/ars.2012.4572
  20. Kim S, Kim HY, Kim JH et al (2015) Enhancement of potency and stability of human extracellular superoxide dismutase. BMB Rep 48, 91-96 https://doi.org/10.5483/BMBRep.2015.48.2.093
  21. Kwon MJ, Han J, Kim BH, Lee YS and Kim TY (2012) Superoxide dismutase 3 suppresses hyaluronic acid fragments mediated skin inflammation by inhibition of toll-like receptor 4 signaling pathway: superoxide dismutase 3 inhibits reactive oxygen species-induced trafficking of toll-like receptor 4 to lipid rafts. Antioxid Redox Signal 16, 297-313 https://doi.org/10.1089/ars.2011.4066
  22. Jeon B, Kim BH, Lee YS, Kim S, Yoon JB and Kim TY (2011) Inactive extracellular superoxide dismutase disrupts secretion and function of active extracellular superoxide dismutase. BMB Rep 44, 40-45 https://doi.org/10.5483/BMBRep.2011.44.1.40
  23. Kim Y, Kim BH, Lee H et al (2011) Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1a and NF-kB pathways. Free Radic Biol Med 51, 1985-1995 https://doi.org/10.1016/j.freeradbiomed.2011.08.027
  24. Uematsu T, Nagashima S, Umemura K, Kanamaru M and Nakashima M (1994) Pharmacokinetics and safety of intravenous recombinant human superoxide dismutase (NK341) in healthy subjects. Int J Clin Pharmacol Ther 32, 638-641

Cited by

  1. Inhibitory effects of superoxide dismutase 3 on Propionibacterium acnes-induced skin inflammation vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-22132-z